HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
-2.55%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.3B
AUM Growth
+$2.3B
(-5.6%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-4.55%
Top 10 Holdings %
Top 10 Hldgs %
49.1%
Holding
90
New
20
Increased
22
Reduced
16
Closed
17
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$125M |
| 2 |
Cencora
COR
|
$75.5M |
| 3 |
Centene
CNC
|
$61.2M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$60M |
| 5 |
McKesson
MCK
|
$56.2M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$106M |
| 2 |
Humana
HUM
|
$106M |
| 3 |
Danaher
DHR
|
$103M |
| 4 |
CVS Health
CVS
|
$92.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
$92.3M |
Sector Composition
| 1 | Healthcare | 89.61% |
| 2 | Consumer Discretionary | 4.54% |
| 3 | Real Estate | 3.95% |
| 4 | Financials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Becton Dickinson
BDX
$54.3B
| $34.5M | 1.49% |
+144,054
| New | +$34.5M |
|
27
Align Technology
ALGN
$9.59B
| $31.1M | 1.34% |
46,730
-72,050
| -61% | -$47.9M |
|
28
Vertex Pharmaceuticals
VRTX
$102B
| $23.6M | 1.02% |
130,290
+12,330
| +10% | +$2.24M |
|
29
Syndax Pharmaceuticals
SNDX
$1.39B
| $23.2M | 1% |
1,214,670
-536,672
| -31% | -$10.3M |
|
30
Idexx Laboratories
IDXX
$50.7B
| $22.3M | 0.96% |
35,800
+5,900
| +20% | +$3.67M |
|
|
LGV
31
DELISTED
Longview Acquisition Corp. II
LGV
| $21.1M | 0.91% |
2,135,900
| – | – |
|
32
Halozyme
HALO
$8.75B
| $20.1M | 0.87% |
493,502
-155,550
| -24% | -$6.33M |
|
33
Zoetis
ZTS
$67.6B
| $16.1M | 0.7% |
83,060
-146,110
| -64% | -$28.4M |
|
|
AFMD
34
DELISTED
Affimed
AFMD
| $15.8M | 0.68% |
255,591
+13,295
| +5% | +$822K |
|
35
Cytokinetics
CYTK
$5.98B
| $15.5M | 0.67% |
434,500
-314,810
| -42% | -$11.3M |
|
|
36
CVS Health
CVS
$93B
| $14.7M | 0.64% |
173,800
-1,093,530
| -86% | -$92.8M |
|
|
DCPH
37
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $13.1M | 0.57% |
386,190
| – | – |
|
|
RACB
38
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $13M | 0.56% |
1,324,800
| – | – |
|
39
Maravai LifeSciences
MRVI
$341M
| $12.3M | 0.53% |
250,000
-1,005,597
| -80% | -$49.4M |
|
|
BHVN
40
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $11.4M | 0.49% |
82,183
+71,183
| +647% | +$9.89M |
|
41
Encompass Health
EHC
$12.5B
| $8.98M | 0.39% |
150,337
-1,176,195
| -89% | -$70.2M |
|
42
Fate Therapeutics
FATE
$115M
| $7.61M | 0.33% |
+128,450
| New | +$7.61M |
|
|
MSAC
43
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $7.25M | 0.31% |
744,000
| – | – |
|
44
BioNTech
BNTX
$24.1B
| $6.47M | 0.28% |
+23,690
| New | +$6.47M |
|
45
RAPT Therapeutics
RAPT
$187M
| $5.74M | 0.25% |
23,088
-1,912
| -8% | -$475K |
|
|
OHPA
46
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
| $5.31M | 0.23% |
547,385
-213
| -0% | -$2.07K |
|
47
Incyte
INCY
$17B
| $5.16M | 0.22% |
+75,000
| New | +$5.16M |
|
|
ARYE
48
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
| $4.94M | 0.21% |
+500,000
| New | +$4.94M |
|
49
Leap Therapeutics
LPTX
$12M
| $4.81M | 0.21% |
+120,000
| New | +$4.81M |
|
|
IMA
50
ImageneBio, Inc. Common Stock
IMA
$153M
| $4.29M | 0.19% |
28,329
-3,134
| -10% | -$475K |
|